查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1772200

美國橫向流動化驗市場規模、佔有率、趨勢分析報告：按產品、應用、技術、最終用途、細分市場預測，2025-2033

U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product, By Application, By Technique, By End use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國橫向流動化驗市場趨勢：

預計 2024 年美國橫向流動化驗市場規模將達到 28.2 億美元，到 2033 年將達到 46.3 億美元，2025 年至 2033 年的複合年成長率為 6.08%。

不斷上升的感染疾病疫情給全球公共衛生系統帶來巨大壓力。隨著都市化加快、互聯互通程度加深、抗生素抗藥性加劇以及氣候變遷的影響日益加劇，專家們強調加強感染疾病監測、預防和診斷能力的迫切需求。全球感染疾病的增加是橫向流動檢測 (LFA) 市場的主要驅動力，該市場需要快速診斷解決方案。根據美國美國病例數將從 2022 年的 7,874 例增加到 2024 年的 10,347 例，這反映出一項顯著的公共衛生挑戰。

由於西尼羅河病毒 (WNV)、登革熱、基孔肯雅病、茲卡病毒、瘧疾和黃熱病等蚊媒性行為感染的盛行率不斷上升，預計蚊媒疾病檢測產業將顯著成長。這些感染疾病的增加對快速有效的診斷解決方案的需求很高，尤其是在疫情易發地區。據美國疾病管制與預防中心 (CDC) 稱，西尼羅河病毒 (WNV) 在美國流行，美國所有 48 個州和哥倫比亞特區均有報告病例，主要發生在夏季和秋季。截至 2024 年 11 月，CDC 已記錄 1,466 例 WNV 感染病例，2022 年報告了 913 例人類病例，其中 70% 為神經侵入性，30% 為非神經侵入性。蚊媒疾病負擔的增加，加上 COVID-19 和猴痘等持續存在的健康危機，凸顯了有效診斷和監測措施的迫切性。

公共衛生工作在擴大市場方面也發揮關鍵作用。美國疾病管制與預防中心（CDC）的國際流感計畫專注於流感監測、大流行防範、調查和疫苗接種計畫。此外，全國縣市衛生負責人協會協助地方衛生部門進行流感預防和應變工作。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國橫向流動化驗市場變數、趨勢與範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國橫向流動化驗市場分析工具
    • 波特分析
    • PESTEL分析

第4章美國橫向流動化驗市場：產品預估與趨勢分析

  • 美國橫向流動化驗市場：產品變異分析
  • 按產品 2024 年及 2033 年
  • 套件和試劑
  • 側向流讀取儀
    • 桌上型讀數儀
    • 數字領袖

第5章美國橫向流動化驗市場：應用評估與趨勢分析

  • 美國橫向流動化驗市場：應用趨勢分析
  • 按應用 2024 年和 2033 年
  • 臨床試驗
    • 傳染病檢查
    • 心臟標記檢測
    • 妊娠和生育能力測試
    • 膽固醇檢測/血脂分析
    • 藥物濫用檢測
    • 其他實驗室檢查
  • 獸醫診斷
  • 食品安全與環境檢測
  • 藥物開發和品質測試

第6章美國橫向流動化驗市場：技術評估與趨勢分析

  • 美國橫向流動化驗市場：技術變革分析
  • 2024年和2033年的技術
  • 夾心試驗
  • 競爭分析
  • 多重檢測分析

第7章美國橫向流動化驗市場：最終用途估計與趨勢分析

  • 美國橫向流動化驗市場：最終用途變異分析
  • 按最終用途分類，2024 年和 2033 年
  • 醫院和診所
  • 診斷實驗室
  • 居家護理
  • 製藥和生物技術公司
  • 其他用途

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • QuidelOrtho Corporation
    • F. Hoffmann-La Roche
    • DH Life Sciences, LLC.
    • Quest Diagnostics
Product Code: GVR-4-68040-646-5

U.S. Lateral Flow Assay Market Trends:

The U.S. lateral flow assay market size was valued at USD 2.82 billion in 2024 and is projected to reach USD 4.63 billion by 2033, growing at a CAGR of 6.08% from 2025 to 2033. The rising prevalence of infectious diseases places immense pressure on public health systems worldwide. With increasing urbanization, interconnectivity, antimicrobial resistance, and the rising impact of climate change, experts stress the urgent need for enhanced infectious disease surveillance, prevention, and diagnostic capabilities. The global rise in infectious diseases significantly drives the lateral flow assays (LFA) market by necessitating rapid diagnostic solutions. According to the Centers for Disease Control and Prevention (CDC), tuberculosis (TB) cases in the U.S. increased from 7,874 in 2022 to 10,347 in 2024, reflecting a notable public health challenge.

The mosquito-borne disease testing segment is projected to experience significant growth due to the rising prevalence of mosquito-borne infections, including West Nile virus (WNV), dengue, chikungunya, Zika virus, malaria, and yellow fever. The increasing incidence of these diseases has heightened the demand for rapid and efficient diagnostic solutions, particularly in regions prone to outbreaks. According to the Centers for Disease Control and Prevention (CDC), West Nile virus (WNV) has become endemic in the U.S., with cases reported in all 48 contiguous states and the District of Columbia, predominantly during the summer and fall months. As of November 2024, the CDC recorded 1,466 cases of WNV, while in 2022, 913 human cases were reported, with 70% classified as neuroinvasive and 30% as non-neuroinvasive. The increasing burden of mosquito-borne diseases, alongside ongoing health crises such as COVID-19 and monkeypox, underscores the urgent need for effective diagnostic and surveillance measures.

Public health initiatives also play a crucial role in market expansion. The CDC's Influenza Division International Program focuses on surveillance, pandemic preparedness, research, and vaccination programs to combat influenza. Additionally, the National Association of County and City Health Officials supports local health departments in influenza prevention and control.

U.S. Lateral Flow Assay Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. lateral flow assay market report based on product, application, technique, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits & Reagents
  • Lateral Flow Readers
  • Benchtop Readers
  • Digital Readers
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Testing
    • Infectious Disease Testing
    • COVID-19
    • Mosquito Borne Disease Testing
    • Malaria Testing
    • Dengue Testing
    • Zika Testing
    • Chikungunya Testing
    • Others
    • Influenza Testing
    • Sexually Transmitted Infection Testing
    • HIV Testing
    • HPV Testing
    • Chlamydia Testing
    • Gonorrhea Testing
    • Syphilis Testing
    • Other STI Testing
    • Hepatitis
    • Tuberculosis
    • Other Infectious Diseases
    • Cardiac Marker Testing
    • Troponin I and T Testing
    • CK-MB Testing
    • BNP and NT-Probnp Testing
    • Myoglobin Testing
    • D-Dimer Testing
    • Other Cardiac Marker Tests
    • Pregnancy & Fertility Testing
    • Pregnancy Testing
    • Fertility Testing
    • Cholesterol Testing/Lipid Profile
    • Drugs of Abuse Testing
    • Other Clinical Tests
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing
  • Technique Outlook (Revenue, USD Million, 2021 - 2033)
  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical & Biotechnology Companies
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Lateral Flow Assay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of infectious diseases
      • 3.3.1.2. Technological advancements in lateral flow
      • 3.3.1.3. Growing adoption in homecare settings
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Stringent Regulations
    • 3.3.3. Market Opportunities Analysis
      • 3.3.3.1. Growing demand for Point-of-Care (POC) Testing
      • 3.3.3.2. Expanding applications beyond healthcare
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Product Recalls
  • 3.4. U.S. Lateral Flow Assay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Lateral Flow Assay Market: Product Estimates & Trend Analysis

  • 4.1. U.S. Lateral Flow Assay Market: Product Movement Analysis
  • 4.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Product 2024 & 2033 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Lateral Flow Readers
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Benchtop Readers
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Digital Readers
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Lateral Flow Assay Market: Application Estimates & Trend Analysis

  • 5.1. U.S. Lateral Flow Assay Market: Application Movement Analysis
  • 5.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Application 2024 & 2033 (USD Million)
  • 5.3. Clinical Testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Infectious Disease Testing
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.2. COVID-19
        • 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.3. Mosquito Borne Disease Testing
        • 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.2. Malaria Testing
          • 5.3.2.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.3. Dengue Testing
          • 5.3.2.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.4. Zika Testing
          • 5.3.2.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.5. Chikungunya Testing
          • 5.3.2.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.3.6. Others
          • 5.3.2.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.4. Influenza Testing
        • 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.5. Sexually Transmitted Infection Testing
        • 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.2. HIV Testing
          • 5.3.2.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.3. HPV Testing
          • 5.3.2.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.4. Chlamydia Testing
          • 5.3.2.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.5. Gonorrhea Testing
          • 5.3.2.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.6. Syphilis Testing
          • 5.3.2.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.3.2.5.7. Other STI Testing
          • 5.3.2.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.6. Hepatitis
        • 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.7. Tuberculosis
        • 5.3.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.2.8. Other Infectious Diseases
        • 5.3.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Cardiac Marker Testing
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.2. Troponin I and T Testing
        • 5.3.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.3. CK-MB Testing
        • 5.3.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.4. BNP and NT-Probnp Testing
        • 5.3.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.5. Myoglobin Testing
        • 5.3.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.6. D-Dimer Testing
        • 5.3.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.3.7. Other Cardiac Marker Tests
        • 5.3.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Pregnancy & Fertility Testing
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.4.2. Pregnancy Testing
        • 5.3.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.4.3. Fertility Testing
        • 5.3.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Cholesterol Testing/Lipid Profile
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.6. Drugs of Abuse Testing
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.7. Other Clinical Tests
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Veterinary Diagnostics
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Food Safety & Environment Testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Drug Development & Quality Testing
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Lateral Flow Assay Market: Technique Estimates & Trend Analysis

  • 6.1. U.S. Lateral Flow Assay Market: Technique Movement Analysis
  • 6.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Technique 2024 & 2033 (USD Million)
  • 6.3. Sandwich Assays
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Competitive Assays
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Multiplex Detection Assays
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Lateral Flow Assay Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Lateral Flow Assay Market: End-use Movement Analysis
  • 7.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by End-use 2024 & 2033 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Home Care
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Pharmaceutical & Biotechnology Companies
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Other End-use
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Bio-Rad Laboratories, Inc
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Siemens Healthineers AG
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. BIOMERIEUX
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. BD
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. QIAGEN
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. QuidelOrtho Corporation
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. F. Hoffmann-La Roche
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. DH Life Sciences, LLC.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Quest Diagnostics
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. lateral flow assay market, by region, 2018 - 2033 (USD Million)
  • Table 3 U.S. lateral flow assay market, by product, 2018 - 2033 (USD Million)
  • Table 4 U.S. lateral flow assay market, by technique, 2018 - 2033 (USD Million)
  • Table 5 U.S. lateral flow assay market, by application, 2018 - 2033 (USD Million)
  • Table 6 U.S. lateral flow assay market, by end-use, 2018 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. lateral flow assay market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. lateral flow assay market: Product outlook key takeaways
  • Fig. 20 U.S. lateral flow assay market: Product movement analysis
  • Fig. 21 Kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Lateral flow readers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Benchtop readers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Digital readers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. lateral flow assay market: Application outlook key takeaways
  • Fig. 26 U.S. lateral flow assay market: Application movement analysis
  • Fig. 27 Clinical testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Infectious disease testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Covid-19 market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Mosquito borne disease testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Malaria Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Dengue Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Zika Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Chikungunya Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Influenza testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Sexually transmitted infection testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 HIV testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 HPV testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Chlamydia testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Gonorrhea testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Syphilis testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Other STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Hepatitis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Tuberculosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Other infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Cardiac marker testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Troponin I and t testing
  • Fig. 49 CK-MB testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 BNP and NT-PROBNP testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Myoglobin testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 D-dimer testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Other cardiac marker tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Pregnancy & fertility testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Pregnancy testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Fertility testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Cholesterol testing/lipid profile market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Drugs of abuse testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Other clinical tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Veterinary diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Food safety & environment testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Drug development & quality testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 U.S. lateral flow assay market: Technique outlook key takeaways
  • Fig. 64 U.S. lateral flow assay market: Technique movement analysis
  • Fig. 65 Sandwich assays market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Competitive assays market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Multiplex detection assays market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 U.S. Lateral Flow Assay market: Test Type outlook key takeaways
  • Fig. 69 U.S. Lateral Flow Assay market: Test Type movement analysis
  • Fig. 70 Lateral flow immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Nucleic acid lateral flow assay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 U.S. Lateral Flow Assay market: End-use outlook key takeaways
  • Fig. 73 U.S. Lateral Flow Assay market: End-use movement analysis
  • Fig. 74 Hospitals & clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Diagnostic laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Home care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Other End-use market estimates and forecasts, 2021 - 2033 (USD Million)